Comparisons Of Baseline Characteristics And Treatment Efficacy In Individuals With Refractory Or Unexplained Chronic Cough Enrolled In Phase 3 Trials Of Gefapixant Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Blaiss, Michael
  • Dicpinigaitis, Peter
  • Birring, Surinder
  • McGarvey, Lorcan
  • Morice, Alyn
  • Pavord, Ian
  • Satia, Imran
  • Smith, Jaclyn
  • La Rosa, Carmen
  • Li, Qing
  • Nguyen, Allison Martin
  • Schelfhout, Jonathan
  • Tzontcheva, Anjela
  • Muccino, David

publication date

  • February 1, 2022